HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of Transcranial Direct-Current Stimulation in Catatonia: A Review and Case Series.

Abstract
Catatonia is a severe neuropsychiatric syndrome, usually treated by benzodiazepines and electroconvulsive therapy. However, therapeutic alternatives are limited, which is particularly critical in situations of treatment resistance or when electroconvulsive therapy is not available. Transcranial direct-current stimulation (tDCS) is a promising non-invasive neuromodulatory technique that has shown efficacy in other psychiatric conditions. We present the largest case series of tDCS use in catatonia, consisting of eight patients in whom tDCS targeting the left dorsolateral prefrontal cortex and temporoparietal junction was employed. We used a General Linear Mixed Model to isolate the effect of tDCS from other confounding factors such as time (spontaneous evolution) or co-prescriptions. The results indicate that tDCS, in addition to symptomatic pharmacotherapies such as lorazepam, seems to effectively reduce catatonic symptoms. These results corroborate a synthesis of five previous case reports of catatonia treated by tDCS in the literature. However, the specific efficacy of tDCS in catatonia remains to be demonstrated in a randomized controlled trial. The development of therapeutic alternatives in catatonia is of paramount importance.
AuthorsAlexandre Haroche, Nolwenn Giraud, Fabien Vinckier, Ali Amad, Jonathan Rogers, Mylène Moyal, Laetitia Canivet, Lucie Berkovitch, Raphaël Gaillard, David Attali, Marion Plaze
JournalFrontiers in psychiatry (Front Psychiatry) Vol. 13 Pg. 876834 ( 2022) ISSN: 1664-0640 [Print] Switzerland
PMID35573356 (Publication Type: Journal Article)
CopyrightCopyright © 2022 Haroche, Giraud, Vinckier, Amad, Rogers, Moyal, Canivet, Berkovitch, Gaillard, Attali and Plaze.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: